D-Serine破坏了Cbln1和GluD1的相互作用,并影响了Cbln1依赖的突触效应和中枢杏仁体中的有害反应
Siddhesh S Sabnis1, Kishore Kumar S Narasimhan1, Poojashree B Chettiar1
1Department of Psychiatry and Behavioral Sciences, Health Sciences Center, School of Medicine, Texas A&M University, 206, Olsen Blvd, Reynolds Medical Sciences Bldg, College Station, TX, 77845, USA.
Cellular and molecular life sciences : CMLS
|January 31, 2025
概括
D-氨酸与谷氨酸三元1受体 (GluD1) 的结合抑制了它们与Cbln1.1的相互作用. 这种调制影响了突触可塑性和疼痛感知,揭示了D-素在中枢神经系统中的新角色.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 突触性可塑性 突触性可塑性
背景情况:
- 离子型谷氨酸受体 (iGluRs) 对于刺激性神经传递至关重要.
- 氨酸作为NMDA受体的联合激动剂和谷氨酸三角体受体 (GluDs) 的低亲和性联体作用.
- 虽然D-素影响GluD2介导的突触可塑性,但其与GluD1和Cbln1的作用尚不清楚.
研究的目的:
- 为了研究D-氨酸对Cbln1和GluD1.1之间的相互作用的影响.
- 确定这种相互作用对突触传输和行为的功能后果.
- 探索D-氨酸在调节Cbln1诱导的突触生成和疼痛中的作用.
主要方法:
- 在体外细胞结合测试以评估Cbln1-GluD1相互作用.
- 中枢桃体 (CeA) 切片中的ex vivo电生理学.
- 在动物模型中进行了涉及CeA内注射的行为研究.
主要成果:
- D-氨酸以度依赖的方式 (IC50 ~ 300μM) 抑制了Cbln1-GluD1相互作用.
- 重组Cbln1在CeA切片中增加了刺激性神经传递和GluD1表达,D-素部分阻断了这种效应.
- 在行为疼痛模型中,D-氨酸抑制了Cbln1的前感觉和反感觉效应.
结论:
- D-氨酸与GluD1的结合减少了它与合成性联体Cbln1.1的相互作用.
- 这种D-氨酸的相互作用调制与突触可塑性有关.
- D-氨酸影响Cbln1介导的突触功能和疼痛行为,这表明一种新的调节机制.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
GPCR Desensitization
5.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.7K


